WRBY insider files Form 144 reporting share sales

WRBY filed a Form 144 disclosing insider share sales under a 10b5-1 plan.

Rhea-AI Filing Summary

WRBY filed a Form 144 disclosing insider share sales under a 10b5-1 plan. The filing lists multiple brokered sales by Neil Blumenthal, including 217,667 shares on 07/01/2026 for $6,446,097.50 and earlier trades in 2026 totaling tens of thousands of shares each.

Key Figures

Sale on 07/01/2026: 217,667 shares Proceeds on 07/01/2026: $6,446,097.50 Sale on 06/29/2026: 36,300 shares +5 more

8 metrics

Sale on 07/01/2026 217,667 shares 10b5-1 sale by Neil Blumenthal

Proceeds on 07/01/2026 $6,446,097.50 Gross proceeds reported for 217,667 shares

Sale on 06/29/2026 36,300 shares 10b5-1 sale by Neil Blumenthal

Proceeds on 06/29/2026 $1,090,564.53 Gross proceeds reported for 36,300 shares

Sale on 05/19/2026 63,040 shares 10b5-1 sale by Neil Blumenthal

Proceeds on 05/19/2026 $1,893,236.19 Gross proceeds reported for 63,040 shares

Sale on 04/17/2026 75,213 shares 10b5-1 sale by Neil Blumenthal

Proceeds on 04/17/2026 $1,847,748.44 Gross proceeds reported for 75,213 shares

Key Terms

10b5-1 Sales, Form 144, Founder Shares, Previously Exercised Options

4 terms

10b5-1 Sales regulatory

"10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founder Shares financial

"Founder Shares & Previously Exercised Options"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

Previously Exercised Options financial

"Founder Shares & Previously Exercised Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does WRBY's Form 144 reveal about insider sales?

The Form 144 shows insiders sold shares under a 10b5-1 plan. It lists trades by Neil Blumenthal on specific dates with share counts and gross proceeds, for example 217,667 shares on 07/01/2026 for $6,446,097.50.

Who executed the sales reported in WRBY's filing?

The filing identifies Neil Blumenthal as the seller, with an address shown and multiple 10b5-1 sales across 2026. Each trade is listed with date, share amount, and gross dollar proceeds in the excerpt.

How many shares and proceeds are shown for the largest trade?

The largest trade in the excerpt is 217,667 shares on 07/01/2026 with gross proceeds of $6,446,097.50, as reported in the Form 144 sales table included in the filing.

Were the sales listed executed under a trading plan?

Yes. The excerpt labels the transactions as 10b5-1 Sales, indicating they were reported under a prearranged trading plan; each row in the excerpt pairs the 10b5-1 label with date, shares, and proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883345
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Warby Parker Inc.
SEC File Number	001-40825
Address of Issuer	233 Spring Street, 6th Floor East New York NEW YORK 10013
Phone	6468477215
Name of Person for Whose Account the Securities are To Be Sold	NEIL BLUMENTHAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9200	269192.00	107094174	07/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/28/2017	Founder Shares & Previously Exercised Options	Issuer			9200	06/28/2017	N/A & Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	07/01/2026	217667	6446097.50
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	06/29/2026	36300	1090564.53
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	05/19/2026	63040	1893236.19
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/20/2026	22442	562957.57
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/17/2026	75213	1847748.44
10b5-1 Sales for NEIL BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	Common	04/16/2026	2345	56466.66

144: Remarks and Signature

Remarks	The securities to be sold were acquired from founder shares and previously exercised options during the period of 06/28/2017 through 12/31/2023.
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil Harris Blumenthal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)